Recent News

• 01.08.2026 - Phathom Pharmaceuticals Announces Pricing of $130 Million Public Offering of Common Stock and Pre-Funded Warrants
• 01.07.2026 - Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
• 01.07.2026 - Phathom Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
• 11.03.2025 - Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
• 10.30.2025 - Phathom Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

Recent Filings

• 01.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 12.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.04.2025 - 8-K Current report